Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | S-1 | tm2321493-8_s1.htm | S-1 | 3142184 |
2 | EXHIBIT 3.1 | tm2321493d9_ex3-1.htm | EX-3.1 | 129208 |
3 | EXHIBIT 3.2 | tm2321493d9_ex3-2.htm | EX-3.2 | 44951 |
4 | EXHIBIT 3.3 | tm2321493d9_ex3-3.htm | EX-3.3 | 160051 |
5 | EXHIBIT 3.4 | tm2321493d9_ex3-4.htm | EX-3.4 | 156102 |
6 | EXHIBIT 4.1 | tm2321493d9_ex4-1.htm | EX-4.1 | 19687 |
7 | EXHIBIT 4.2 | tm2321493d9_ex4-2.htm | EX-4.2 | 15512 |
8 | EXHIBIT 4.3 | tm2321493d9_ex4-3.htm | EX-4.3 | 13257 |
9 | EXHIBIT 4.4 | tm2321493d9_ex4-4.htm | EX-4.4 | 13781 |
10 | EXHIBIT 4.5 | tm2321493d9_ex4-5.htm | EX-4.5 | 215519 |
11 | EXHIBIT 10.1 | tm2321493d9_ex10-1.htm | EX-10.1 | 219039 |
12 | EXHIBIT 10.2 | tm2321493d9_ex10-2.htm | EX-10.2 | 360041 |
13 | EXHIBIT 10.3 | tm2321493d9_ex10-3.htm | EX-10.3 | 80096 |
14 | EXHIBIT 10.4 | tm2321493d9_ex10-4.htm | EX-10.4 | 77926 |
15 | EXHIBIT 10.5 | tm2321493d9_ex10-5.htm | EX-10.5 | 30494 |
16 | EXHIBIT 10.6 | tm2321493d9_ex10-6.htm | EX-10.6 | 95836 |
17 | EXHIBIT 10.7 | tm2321493d9_ex10-7.htm | EX-10.7 | 153490 |
18 | EXHIBIT 10.8 | tm2321493d9_ex10-8.htm | EX-10.8 | 63748 |
19 | EXHIBIT 10.9 | tm2321493d9_ex10-9.htm | EX-10.9 | 88795 |
20 | EXHIBIT 10.13 | tm2321493d9_ex10-13.htm | EX-10.13 | 19696 |
21 | EXHIBIT 10.14 | tm2321493d9_ex10-14.htm | EX-10.14 | 93530 |
22 | EXHIBIT 23.1 | tm2321493d9_ex23-1.htm | EX-23.1 | 1864 |
23 | EX-FILING FEES | tm2321493d9_ex-filingfees.htm | EX-FILING FEES | 14806 |
24 | GRAPHIC | bc_plasma-4c.jpg | GRAPHIC | 48472 |
25 | GRAPHIC | fc_fig01invea-4c.jpg | GRAPHIC | 123249 |
26 | GRAPHIC | fc_fig03dysreg-4c.jpg | GRAPHIC | 100336 |
27 | GRAPHIC | fc_fig04cellbio-4c.jpg | GRAPHIC | 87512 |
28 | GRAPHIC | fc_fig05inflama-4c.jpg | GRAPHIC | 73109 |
29 | GRAPHIC | fc_fig06mediator-4c.jpg | GRAPHIC | 121937 |
30 | GRAPHIC | fc_imidsubmet-4c.jpg | GRAPHIC | 96436 |
31 | GRAPHIC | fc_lpsatpmousemodel-4c.jpg | GRAPHIC | 90649 |
32 | GRAPHIC | fc_pipelinee-4c.jpg | GRAPHIC | 81570 |
33 | GRAPHIC | fc_triggers-4c.jpg | GRAPHIC | 91384 |
34 | GRAPHIC | lc_fig08primary-bw.jpg | GRAPHIC | 25358 |
35 | GRAPHIC | lc_fig09igascor01-bw.jpg | GRAPHIC | 17748 |
36 | GRAPHIC | lc_fig09igascor02-bw.jpg | GRAPHIC | 17628 |
37 | GRAPHIC | lc_fig12plasma-bw.jpg | GRAPHIC | 78478 |
38 | GRAPHIC | lc_fig14inva8001-bw.jpg | GRAPHIC | 56455 |
39 | GRAPHIC | lg_inveatherapeutics-4c.jpg | GRAPHIC | 11997 |
40 | GRAPHIC | ph_intactskin-4c.jpg | GRAPHIC | 420748 |
41 | GRAPHIC | tb_adseverity-4c.jpg | GRAPHIC | 26690 |
42 | GRAPHIC | tb_assesment-4c.jpg | GRAPHIC | 58841 |
43 | GRAPHIC | tb_enzyme-4c.jpg | GRAPHIC | 31243 |
44 | GRAPHIC | tb_mean-bw.jpg | GRAPHIC | 60519 |
45 | GRAPHIC | tb_placebo-4c.jpg | GRAPHIC | 47029 |
46 | GRAPHIC | tb_report-4c.jpg | GRAPHIC | 167503 |
47 | GRAPHIC | tb_system-4c.jpg | GRAPHIC | 139705 |
48 | GRAPHIC | tb_system01-4c.jpg | GRAPHIC | 125998 |
49 | GRAPHIC | tb_system02-4c.jpg | GRAPHIC | 196534 |
50 | GRAPHIC | tbl_majortheraoeutic-4c.jpg | GRAPHIC | 281569 |
Complete submission text file | 0001104659-23-110477.txt | 8879051 |
IRS No.: 873198325 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-275109 | Film No.: 231337228
SIC: 2834 Pharmaceutical Preparations